Heron Neutron Medical (禾榮科技) has signed a strategic partnership agreement with Siemens Healthineers to integrate Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT) with world-leading imaging technologies. The collaboration aims to create an AI-driven "Theranostics" (Therapeutic + Diagnostic) platform.

• Precision Integration: The partnership will combine Heron’s AB-BNCT clinical system with Siemens’ cutting-edge platforms, such as Photon-Counting CT (PCCT). This integration optimizes the entire clinical pathway—from patient screening and treatment planning to precision delivery and post-treatment follow-up.
• Strategic Upgrade: Heron Neutron Medical GM Shen Hsiao-lien emphasized that this moves AB-BNCT beyond a standalone "advanced therapy" into an "intelligent image-guided platform," enhancing international competitiveness and clinical predictability.
• Clinical Vision: Siemens Healthineers GM Chiu Chen-hsiang highlighted that this collaboration will set new clinical standards for personalized, high-precision cancer care.

Resource: 禾榮科技攜手西門子醫療 共建AI驅動AB-BNCT診療一體化平台